$30M collaboration focuses on therapies for viral infections
Harvard University and AbbVie today announced a $ 30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel therapies against emergent viral infections, with a focus on those caused by coronaviruses and by viruses that lead to hemorrhagic fever. This collaboration aims to rapidly integrate fundamental… Read More »